Goldman Sachs
TENX icon

Goldman Sachs’s Tenax Therapeutics TENX Stock Holding History

Goldman Sachs’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$509K Buy
31,854
+9,445
+42% +$128K ﹤0.01% 5583
2025
Q4 		$273K Buy
+22,409
New +$195K ﹤0.01% 5909
2020
Q3 		– Sell
-14
Closed -$20K – 5535
2020
Q2 		$20K Buy
+14
New +$20.6K ﹤0.01% 5127
2016
Q2 		– Sell
-1
Closed -$54K – 7251
2016
Q1 		$54K Hold
1
– – ﹤0.01% 6387
2015
Q4 		$84K Hold
1
– – ﹤0.01% 6276
2015
Q3 		$64K Hold
1
– – ﹤0.01% 6688
2015
Q2 		$79K Hold
1
– – ﹤0.01% 6719
2015
Q1 		$73K Hold
1
– – ﹤0.01% 6566
2014
Q4 		$136K Sell
1
-1
-50% -$121K ﹤0.01% 6422
2014
Q3 		$190K Buy
+2
New +$257K ﹤0.01% 6210

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs's TENX Position: Q1 2026 in Review

Goldman Sachs increased its Tenax Therapeutics (TENX) stake by 42% in Q1 2026, buying an estimated $128K and bringing the position to 31,854 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #5583.

Goldman Sachs first reported a position in TENX in Q3 2014 and has held it in 10 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Goldman Sachs held 31,854 shares of Tenax Therapeutics worth $509K as of Q1 2026.
  • Goldman Sachs bought 9,445 Tenax Therapeutics shares in Q1 2026, an estimated $128K.
  • Tenax Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5583 holding.
  • Goldman Sachs first reported a position in Tenax Therapeutics in Q3 2014 and has held it in 10 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.